Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry
BackgroundThe outcome of COVID-19 in allogeneic hematopoietic stem cell transplantation (HSCT) recipients is almost uniformely considered poor. The aim of present study was to retrospectively analyse the outcome and risk factors for mortality in a large series of patients who developed COVID-19 infe...
Similar Items
-
Necrotizing pancreatitis with invasive candidiasis and candidemia due to Candida albicans and pan-echinocandin-resistant Candida glabrata
by: Laman Rahimli, et al.
Published: (2024-03-01) -
From words to pixels: The Infectious Diseases in Motion (IDIM) and VACCELERATE experience for fast and accessible science audiovisual communication
by: Jon Salmanton-García, et al.
Published: (2023-12-01) -
Monkeypox diagnostic and treatment capacity at epidemic onset: A VACCELERATE online survey
by: Jan Hendrik Grothe, et al.
Published: (2022-10-01) -
NIRMATRELVIR/RITONAVIR (NIRI) EM PACIENTES COM COVID-19 E MALIGNIDADES HEMATOLÓGICAS: RELATO DO EPICOVIDEHA (REGISTRO INTERNACIONAL ONLINE DE PACIENTES COM MALIGNIDADES HEMATOLÓGICAS, INFECTADOS POR SARS-COV-2)
by: Jon Salmanton-García, et al.
Published: (2023-10-01) -
MELHOR DESFECHO CLÍNICO DA COVID-19 EM PACIENTES COM MALIGNIDADE HEMATOLÓGICA QUE RECEBERAM UMA QUARTA DOSE DA VACINA ANTI-SARS-COV-2: EPICOVIDEHA (REGISTRO INTERNACIONAL ONLINE DE PACIENTES COM MALIGNIDADES HEMATOLÓGICAS, INFECTADOS POR SARS-COV-2)
by: Jon Salmanton-Garcia, et al.
Published: (2023-10-01)